EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 5, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2020.4741?guestAccessKey=7e296d82-0d7f-4868-b72f-aeb23a39b6aa&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110520
What The Study Did: Changes in rates and risk factors over more than a decade in the U.S. for hospitalizations for a vision-threatening eye infection related to intravenous (IV) drug use were investigated in this study.
Authors: David M. Hinkle, M.D., of the West Virginia University School of Medicine in Morgantown, is the corresponding author.
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.